Completed PHASE4 INTERVENTIONAL 2-arm NCT01940419

Testing of the Drug Tranexamic Acids as Prophylaxis of Bleeding in Benign Surgical Removal of the Uterus (PeTraH)

Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial

Sponsor: Central Denmark Region

Conditions Gynecologic Surgical Procedures Hysterectomy Tranexamic Acid

Interventions Placebo Tranexamic Acid

Updated 6 times since 2017 Last updated: Oct 21, 2015 Started: Apr 30, 2013 Primary completion: Nov 30, 2014 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Gynecologic Surgical Procedures and Hysterectomy, this trial is completed. The trial is conducted by Central Denmark Region and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Central Denmark Region
Hillerod Hospital, Denmark
Odense University Hospital
Research grant from Nordsjællands Hospital
Rigshospitalet, Denmark
The Danish hysterectomy and hysteroscopy database
The fund of Olga Bryde

Data source: Hillerod Hospital, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hillerød, Denmark